$10M Avandia Fee Fight Correctly Resolved, Justices Told
The steering committee involved in centralized product-liability suits against GlaxoSmithKline LLC over diabetes drug Avandia has urged the U.S. Supreme Court to reject the Girardi Keese Law Firm's attempt to avoid...To view the full article, register now.
Already a subscriber? Click here to view full article